SNGX Schedule 13G: Intracoastal and Individuals Report 4.99% Ownership
Rhea-AI Filing Summary
Soligenix Schedule 13G summary: This filing reports that Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital, LLC (the Reporting Persons) each may be deemed to beneficially own 446,408 shares of Soligenix common stock, representing 4.99% of the class as of the close of business on October 1, 2025. The filing explains ownership arises from warrants issued under a Securities Purchase Agreement dated September 25, 2025 and details earlier potential beneficial ownership figures tied to issuance and exercise of three warrants and a contemplated issuance of 425,000 shares to Intracoastal at closing. Blocker provisions in the warrants limit exercise to remain at or below specified ownership thresholds.
Positive
- None.
Negative
- None.
Insights
TL;DR: Passive holdings reported at 4.99% following an SPA; warrants with blocker provisions constrain exercised ownership.
The Schedule 13G discloses passive beneficial ownership by two individuals and an affiliated LLC each holding 446,408 shares, equal to 4.99% of Soligenix on the stated basis. The filing ties these holdings to warrants and a securities purchase agreement executed September 25, 2025 and notes blocker provisions that prevent exercise beyond specified ownership caps. For investors, this indicates disclosure and compliance with SEC passive investor reporting rather than an active attempt to influence control.
TL;DR: Ownership is reported as passive and limited by warrant blocker clauses, reducing governance/control implications.
The report specifies that Intracoastal and the two named individuals are filing under Schedule 13G, asserting the securities are not held to change or influence issuer control. The document details how blocker provisions in three warrants limit potential conversion and help maintain ownership below control thresholds (0.99% or 4.99% as applicable). This filing therefore signals adherence to reporting rules and limited governance impact from these holdings.
FAQ
What percentage of Soligenix (SNGX) does each reporting person beneficially own?
Why does the filing reference warrants and a Securities Purchase Agreement dated September 25, 2025?
Do the reporting persons claim they seek to influence control of Soligenix?
What are the blocker provisions mentioned in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.